Mark D. Carr
Impact in
- Infectious Diseases top 2%
- Tuberculosis Research and Epidemiology
- Oncology top 5%
- Peptidase Inhibition and Analysis
Papers in
-
- RNA and protein synthesis mechanisms 12
- Protein Structure and Dynamics 11
- Glycosylation and Glycoproteins Research 7
- RNA Research and Splicing 6
- Immunology 17
- Toxin Mechanisms and Immunotoxins 7
- Co-authors
- P. Andrew Karplus (1 shared paper)Robert P. Hausinger (1 shared paper)Evelyn Jabri (1 shared paper)Richard A. Williamson (11 shared papers)Frederick W. Muskett (28 shared papers)Václav Veverka (20 shared papers)J. Feeney (15 shared papers)Philip S. Renshaw (11 shared papers)
- Journals
- Journal of Biological Chemistry (20 papers)Biochemistry (7 papers)European Journal of Biochemistry (5 papers)Oncogene (3 papers)Proceedings of the National Academy of Sciences (3 papers)
- Partner nations
- United KingdomGermanyTanzania
In The Last Decade
Mark D. Carr
68 papers receiving 3.5k citations
Mark D. Carr's Hit Papers
Peers
Comparison fields: 5 of 135
- Infectious Diseases 657
- Oncology 814
- Molecular Medicine 156
- Immunology 548
- Molecular Biology 1.7k
Countries citing papers authored by Mark D. Carr
This map shows the geographic impact of Mark D. Carr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark D. Carr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark D. Carr more than expected).
Fields of papers citing papers by Mark D. Carr
This network shows the impact of papers produced by Mark D. Carr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark D. Carr. The network helps show where Mark D. Carr may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark D. Carr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The crystal structure of urease from Klebsiella aerogenes Hit paper breakdown → | 1995 | 737 |
| 2 | 2002 | 281 | |
| 3 | 2013 | 269 | |
| 4 | 2005 | 265 | |
| 5 | 2009 | 199 | |
| 6 | 2007 | 130 | |
| 7 | 1997 | 105 | |
| 8 | 1990 | 98 | |
| 9 | 1994 | 92 | |
| 10 | 2012 | 81 | |
| 11 | 1998 | 74 | |
| 12 | 2011 | 70 | |
| 13 | 2006 | 61 | |
| 14 | 1994 | 54 | |
| 15 | 2008 | 46 | |
| 16 | 2003 | 46 | |
| 17 | 2011 | 46 | |
| 18 | 1994 | 46 | |
| 19 | 1992 | 45 | |
| 20 | 2007 | 44 |
About Mark D. Carr
Mark D. Carr is a scholar working on Molecular Biology, Immunology, Oncology, Infectious Diseases and Materials Chemistry, having authored 69 papers that have together received 3.6k indexed citations. Recurring topics across this work include RNA and protein synthesis mechanisms (12 papers), Protein Structure and Dynamics (11 papers), Tuberculosis Research and Epidemiology (9 papers), Enzyme Structure and Function (8 papers), Glycosylation and Glycoproteins Research (7 papers), Monoclonal and Polyclonal Antibodies Research (7 papers), Toxin Mechanisms and Immunotoxins (7 papers) and RNA Research and Splicing (6 papers). The work is most often cited by research in Infectious Diseases (657 citations), Oncology (814 citations), Molecular Medicine (156 citations), Immunology (548 citations) and Molecular Biology (1.7k citations). Mark D. Carr has collaborated with scholars based in United Kingdom, Germany and Tanzania. Frequent co-authors include P. Andrew Karplus, Robert P. Hausinger, Evelyn Jabri, Richard A. Williamson, Frederick W. Muskett, Václav Veverka, J. Feeney, Philip S. Renshaw, R. Glyn Hewinson and Stephen V. Gordon. Their work appears in journals such as Journal of Biological Chemistry, Biochemistry, European Journal of Biochemistry, Oncogene and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.